Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
Status:
Recruiting
Trial end date:
2030-07-01
Target enrollment:
Participant gender:
Summary
Assess the impact of eplerenone (initiated within 2 hours prior to patient departure to the
operating room and administered for 4 days during the post-operative period) on graft
function evaluated by the measurement of glomerular filtration rate at 3 months - variable
strongly associated with long-term graft survival.